MarginsXMarginsX
Home › Canada › TSX stocks › AVNT

Avant Brands Inc. (TSX: AVNT)

AVNT trades on the Toronto Stock Exchange in Life Sciences, headquartered in Ontario. Numbers below come from the TMX issuer list, Yahoo Finance closes and the Bank of Canada rate, each with its source.

Close · November 13, 2026
C$0.5900
+7.27% on the day
Market cap (C$)
C$8.0M
TMX list, October 31, 2026
Market cap (US$)
US$5.6M
Nano cap at 1.4257 C$/US$
1-year return
-6.3%
-34.4% year to date

Issuer list, sector and C$ market cap: TMX Group TSX and TSXV listed companies, as of October 31, 2026. US$ figures convert C$ at 1.4257 C$ per US$, the Bank of Canada daily rate for November 13, 2026. Close and returns: Yahoo Finance daily closes for AVNT.TO, last bar 2026-11-13, computed by MarginsX.

Profile

FieldValue
TickerAVNT on the Toronto Stock Exchange
Yahoo symbolAVNT.TO
SectorLife Sciences, Cannabis
HeadquartersOntario
Listed2021-07-12
Listing typeTSXV Grad
Shares outstanding15,372,549
Also listed onNo interlisting on the TMX list
Index membershipNot in an S&P/TSX index per the TMX list
SEC CIKNo SEC filer matched on exact name with a Canadian address or US interlisting
WebsiteNo company website on record

Returns

WindowReturn
1 day+7.3%
1 week+5.4%
1 month+13.5%
3 months-9.2%
6 months-1.7%
Year to date-34.4%
1 year-6.3%
From 52-week high-43.8%
52-week rangeC$0.4600 to C$1.05

Links

SEDAR+ is linked for searching only; nothing on this page is taken from it.

Recent Canadian filings by type

83 documents in 5 types. Each title links to the document at its source.

Interim financial statements (27)

DocumentTypeFiled
‍Q3 2025 Q1‍ ‍Q2‍ ‍Q3‍ ‍Q4 2024 Q1‍ ‍Q2‍ ‍
Period Q4 2025
Interim financial statementsNo date
2024 Q1‍ ‍Q2‍ ‍Q3‍ ‍Q4 2023 Q1‍ ‍Q2‍ ‍Q3‍ ‍
Period Q4 2023
Interim financial statementsNo date
Q3‍ ‍Q4 2023 Q1‍ ‍Q2‍ ‍Q3‍ ‍Q4 2022 Q1‍ ‍Q2‍ ‍
Period Q3 2023
Interim financial statementsNo date
2022 Q1‍ ‍Q2‍ ‍Q3‍ ‍Q4 2021 Q1‍ ‍Q2‍ ‍
Period Q4 2022
Interim financial statementsNo date

MD&A (26)

News release (23)

Management information circular / proxy (3)

DocumentTypeFiled
Management Information Circular Form of Proxy NI Card #block-cba8826f18ceddfa5738 { --stroke-style: none;--stroke-thickness: 6px; }…Management information circularNo date
Management Information CircularManagement information circularNo date
Form of ProxyForm of proxy / voting instructionNo date

Other (4)

DocumentTypeFiled
DOWNLOAD #block-yui_3_17_2_1_1625959137716_48536 {
Period Q2 2026
Investor presentationNo date
DOWNLOAD #block-yui_3_17_2_1_1695074725880_17939 {Investor presentationNo date
Q2‍ ‍Q3‍ ‍Q4 2024 Q1‍ ‍Q2‍ ‍Q3‍ ‍Q4 2023 Q1‍ ‍
Period Q4 2024
OtherNo date
LEARN MOREOtherNo date

Sources: Company investor-relations website (links only, documents not copied). Documents filed only on SEDAR+ are not copied here; search SEDAR+ for the full record.

Trading halts

No CIRO halt notices for this company in our data.

Source: Canadian Investment Regulatory Organization (CIRO), Halts/Resumptions newsroom, notices since 2024-10-15.

Upcoming events

No upcoming earnings date, call or meeting announced in the SEC filings and newswire releases we read.

Source: dates read from the company's SEC filings and newswire releases; each row links to the announcement.

Peers in Life Sciences

TickerCompanyExchangeMarket cap (C$)1 month1 year
RKVRakovina Therapeutics Inc.TSXVC$8.2M-15.9%+15.6%
MRVLMarvel Biosciences Corp.TSXVC$8.9M+18.2%-29.7%
ASGAurora Spine CorporationTSXVC$8.9M-32.1%-68.3%
CSCICOSCIENS Biopharma Inc.TSXC$8.9M-14.2%-71.1%
SEGNSeegnal Inc.TSXVC$9.4M0.0%-35.5%

The app has the price chart, every filing, private raises and the full peer set for AVNT.

Open in the app